| Literature DB >> 35136783 |
Sangita D Kamath1, Vinit K Gautam1.
Abstract
INTRODUCTION: Organophosphate compounds (OPC) cause most self-poisoning deaths in India due to their easy availability and lack of stringent laws. AIM: To evaluate the clinical profile and outcome of the patients presenting with OPC poisoning and to study the prognostic value of Peradeniya Organophosphorus Poisoning Scale (POPS) in predicting the clinical outcomes. METHODS AND MATERIALS: This was a prospective study involving 100 patients of OPC poisoning admitted to Tata Main Hospital from June 2018 to May 2020 based on the inclusion criteria. Demographic profile, clinical features, treatment details, and need for ventilatory support were noted. POPS was applied on admission, and the patients were followed up for the outcome in terms of morbidity and mortality. OBSERVATIONS: Of the 100 patients, most patients were between 20 and 29 years with male to female ratio being 1.2:1. Vomiting (94%), followed by excessive secretions (84%) were the most common symptoms. Overall mortality was 22%. On grading of severity as per the POP scale, 27% of the patients had mild poisoning, 37% patients had moderate, whereas 36% had severe poisoning. Only 11.11% of the patients with POPS 0-3 required ventilator support, whereas 16.2% of the patients with POPS 4-7, and 100% of patients with POPS 8-11 required ventilator assistance (P < 0.0001). Similarly, the total dose of atropine required (P < 0.0001), length of intensive care unit (ICU) stay, complications, and mortality (P < 0.0001) were significantly associated with higher POPS.Entities:
Keywords: Clinical score; organophosphorus; pesticides; poisoning; respiratory
Year: 2021 PMID: 35136783 PMCID: PMC8797078 DOI: 10.4103/jfmpc.jfmpc_518_21
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Peradeniya Organophosphorus Poisoning (POP) scale
| Parameters | Value | Points |
|---|---|---|
| Pupil size | >2 mm | 0 |
| <2 mm | 1 | |
| Pin point | 2 | |
| Respiratory rate | >20 | 0 |
| <20 | 1 | |
| <20 with central cyanosis | 2 | |
| Heart Rate | >60 | 0 |
| 41-60 | 1 | |
| <40 | 2 | |
| Fasciculations | Absent | 0 |
| Present-generalized/continuous | 1 | |
| Generalized and continuous | 2 | |
| Level of Consciousness | Conscious and coherent | 0 |
| Impaired | 1 | |
| No response to verbal commands | 2 | |
| Seizures | Absent | 0 |
| Present | 1 |
Figure 1Age and gender distribution of patients (n = 100)
Figure 2Bar diagram showing frequency of symptoms (n = 100)
Figure 3Pie chart showing the distribution of severity of cases as per POP score (n = 100)
Association between POP score and need for ventilator support
| POPS Severity | Ventilator Support | Total | Chi square |
| |
|---|---|---|---|---|---|
|
| |||||
| No | Yes | ||||
| Mild | |||||
| Count | 24 | 3 | 27 | 68.914 | |
| percent | 88.89% | 11.11% | 100.0 | ||
| Moderate | |||||
| Count | 31 | 6 | 37 | ||
| Percent | 83.78% | 16.22% | 100.0 | ||
| Severe | |||||
| Count | 0 | 36 | 36 | ||
| Percent | 0.00% | 100.00% | 0.00% | ||
Correlation between POPS score and clinical outcome (survival) (n=100)
| POPS Scale | Outcome | Chi square |
| |
|---|---|---|---|---|
|
| ||||
| Expired | Survived | |||
| Mild (score 0-3) | ||||
| Count | 1 | 26 | 36.918 | |
| Percent | 3.70% | 96.30% | ||
| Moderate (score 4-7) | ||||
| Count | 2 | 36 | ||
| Percent | 5.4% | 94.6% | ||
| Severe (score 8-11) | ||||
| Count | 19 | 16 | ||
| Percent | 52.8% | 48.2% | ||
Comparison of individual components of POP scale in predicting the clinical outcome
| POP parameters | Points | Survival | Total | Chi square |
| |
|---|---|---|---|---|---|---|
|
| ||||||
| Yes | No | |||||
| Miosis | 0 | 42 | 1 | 43 | 36.651 | |
| 1 | 22 | 2 | 24 | |||
| 2 | 14 | 19 | 33 | |||
| Fasciculations | 0 | 70 | 6 | 76 | 38.491 | |
| 1 | 6 | 8 | 14 | |||
| 2 | 2 | 8 | 10 | |||
| Respiratory rate | 0 | 55 | 0 | 55 | 54.557 | |
| 1 | 22 | 10 | 32 | |||
| 2 | 1 | 12 | 13 | |||
| Pulse rate | 0 | 64 | 2 | 66 | 50.736 | |
| 1 | 12 | 8 | 20 | |||
| 2 | 2 | 12 | 14 | |||
| Level of consciousness | 0 | 56 | 8 | 64 | 50.736 | |
| 1 | 20 | 11 | 31 | |||
| 2 | 2 | 3 | 5 | |||
| Seizures | 0 | 70 | 14 | 84 | 8.615 | |
| 1 | 8 | 8 | 16 | |||